Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta
about
The Dietary Supplement Protandim® Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx MiceSPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophyAnti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factorsModifier genes and their effect on Duchenne muscular dystrophyDonor satellite cell engraftment is significantly augmented when the host niche is preserved and endogenous satellite cells are incapacitatedThe mdx mouse model as a surrogate for Duchenne muscular dystrophyMechanisms of fibrosis: therapeutic translation for fibrotic diseaseTransplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumorsPotent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy.Osteopontin enhances multi-walled carbon nanotube-triggered lung fibrosis by promoting TGF-ß1 activation and myofibroblast differentiationTargeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor.Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.Osteopontin, inflammation and myogenesis: influencing regeneration, fibrosis and size of skeletal muscleThe effects of MyD88 deficiency on disease phenotype in dysferlin-deficient A/J mice: role of endogenous TLR ligands.Eccentric muscle challenge shows osteopontin polymorphism modulation of muscle damageRNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment.Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx miceMechanisms of muscle weakness in muscular dystrophyTGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscleLong-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac functionExpression and function of osteopontin in vascular adventitial fibroblasts and pathological vascular remodelingPharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trialsTransforming growth factor-beta (TGF- β) signaling in paravertebral muscles in juvenile and adolescent idiopathic scoliosis.A special population of regulatory T cells potentiates muscle repair.Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury.Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2.Duchenne muscular dystrophy gene therapy: Lost in translation?Age-related impairment of T cell-induced skeletal muscle precursor cell function.Genetic Modifiers for Neuromuscular DiseasesIdentification of a conserved set of upregulated genes in mouse skeletal muscle hypertrophy and regrowthOsteopontin is induced by TGF-β2 and regulates metabolic cell activity in cultured human optic nerve head astrocytes.Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.Role of TGF-β signaling in inherited and acquired myopathies.Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophyOsteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia.Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophyCorrelation between ovarian neoplasm and serum levels of osteopontin: a meta-analysis.Matricellular proteins in cardiac adaptation and disease.A reporter mouse for optical imaging of inflammation in mdx musclesAbbreviated exposure to hypoxia is sufficient to induce CNS dysmyelination, modulate spinal motor neuron composition, and impair motor development in neonatal mice
P2860
Q24628875-E4F2F640-6777-4571-945D-479E239E4229Q24630041-429E312F-1ED7-4A3E-85B7-D4C7FF120F12Q28069464-FA50D315-B632-4FAC-8FDF-55FA2B79F1DFQ28083441-105B4CCD-1BDA-48D7-96C7-5C9C0AC83BD4Q28389517-E895102A-C211-4E5D-A222-A21358DD5898Q28656377-68D8A575-8879-4698-8AF3-770FCF65574BQ29620307-6BC1B3B5-3D96-4127-BE49-0042C8FEAB24Q30499092-6578E654-517F-4037-B8A2-2D16D37F7E1CQ30841381-6714952B-744A-4BB7-8B51-9B1949710C81Q32944362-E486C99A-60D1-49F7-BDF3-36185BB91CAEQ33570741-89FEAD4D-8DE9-4D96-A4A8-F67FD0C4FD55Q33588636-513A6E63-8606-49BE-86EB-A43D48E14038Q33779868-968CF06C-1968-4AC7-A9F9-B60EFE4A051CQ33808490-E1C58BB7-74E2-4260-B1E8-B172BECEA8B2Q33847615-1AD64F68-CE79-426B-ACFA-DC4B9D0A713FQ33915924-4D94E9DB-5C6C-446D-B7A4-0304883C9AA5Q33925571-05585EF2-3CED-429C-9847-22AEB79BC0ACQ33950716-C2441FED-4D88-45D3-AC1B-C0F70DDDC31CQ33999138-2D502910-D679-410A-8622-915E92A20AECQ34005353-2F718909-BDE7-4D42-BE07-A76BC7B1AE37Q34031217-D8BC1F73-EFEE-47E4-A0F0-05CF0BF45D01Q34152280-80C8673E-F122-4436-8B61-8F74CB1C490FQ34275449-CEEACEEA-EB75-4C6E-B605-09674F33D3E4Q34390308-ABA48505-3054-454C-9BC3-BA515EC4F599Q34421842-0C66FC7E-354D-4872-883E-ED8361044347Q34542698-DC34EB5B-93BE-40C0-A755-4EA65B97DBF0Q35052506-13047814-5E32-46FF-99DD-33C475CCDE80Q35055585-7D9436A3-CF2C-4542-BF32-2B7BA84DA412Q35119976-7B37E24C-AC4D-407A-A4D8-60329B43B6F6Q35141339-94722C58-EFB6-4765-83F2-178AFE429728Q35144030-5E54E2AA-3D0C-49C6-9B10-EEDBEB78FA4CQ35145764-4EF8A6EB-F380-4A2E-9C2B-ADC736059339Q35166254-ECFBEC42-F2FF-44F4-AFA1-02EA8171F768Q35175749-9B2C3081-E9E9-464D-BBCB-0E50109AC398Q35206908-42EDA15A-6AB7-48C4-B576-9141F19BA3BAQ35234073-8D22FD15-E05A-462F-9FCD-201603AF4822Q35240154-072B4F23-1C19-4233-99F3-5D9A2D2D1B90Q35542423-8F5ECF0F-92BB-41EC-B3BC-47824DCA5578Q35576368-A26A3FC8-1FD7-4625-AB61-B3AD1941E4B0Q35644564-3EE53248-A53D-4CC5-8FE9-A2B738D3E129
P2860
Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Osteopontin promotes fibrosis ...... ets and intramuscular TGF-beta
@ast
Osteopontin promotes fibrosis ...... ets and intramuscular TGF-beta
@en
Osteopontin promotes fibrosis ...... ets and intramuscular TGF-beta
@nl
type
label
Osteopontin promotes fibrosis ...... ets and intramuscular TGF-beta
@ast
Osteopontin promotes fibrosis ...... ets and intramuscular TGF-beta
@en
Osteopontin promotes fibrosis ...... ets and intramuscular TGF-beta
@nl
prefLabel
Osteopontin promotes fibrosis ...... ets and intramuscular TGF-beta
@ast
Osteopontin promotes fibrosis ...... ets and intramuscular TGF-beta
@en
Osteopontin promotes fibrosis ...... ets and intramuscular TGF-beta
@nl
P2093
P2860
P3181
P356
P1476
Osteopontin promotes fibrosis ...... ets and intramuscular TGF-beta
@en
P2093
Elena Kudryashova
Encarnacion Montecino-Rodriguez
Eric P Hoffman
Irina Kramerova
M Carrie Miceli
Melissa J Spencer
Scot D Liu
Sylvia A Vetrone
P2860
P304
P3181
P356
10.1172/JCI37662
P407
P577
2009-06-01T00:00:00Z